IDO1, one of tryptophan metabolizing enzymes, was demonstrated to correlate with low tumor infiltration of T cells in colorectal cancer (Brandacher et al., 2006), ovarian cancer (Inaba et al., 2009), and endometrial cancer (Ino et al., 2008). The gene discussed is IDO1; the disease is neoplasm.